Differential impact of asparaginase discontinuation on outcomes of children with T‐cell acute lymphoblastic leukemia and T‐cell lymphoblastic lymphoma

Documenti analoghi

• Localized Lymphoblastic Lymphoma in Children and Adolescents: Results of the LLB‐NHL03 Trial—A Report From the Japan Children's Cancer Group
  di: Masahiro Sekimizu, et al.
  Pubblicazione: (2025)
• Infant acute lymphoblastic leukaemia—Progress from worldwide clinical efforts
  di: Neil Barrett, et al.
  Pubblicazione: (2025)
• Immunological assessment of a patient with infant acute lymphoblastic leukemia
  di: Masatoshi Takagi, et al.
  Pubblicazione: (2024)
• Better late than never: Delayed asparaginase during induction for acute lymphoblastic leukaemia in adults
  di: Yannis K. Valtis, et al.
  Pubblicazione: (2024)
• The correlation of asparaginase enzyme activity levels after PEG‐asparaginase administration with clinical characteristics and adverse effects in Chinese paediatric patients with acute lymphoblastic leukaemia
  di: Cai Chen, et al.
  Pubblicazione: (2024)